Please assess the completion status of the following clinical trial:

Trial Title: Improving Glycogen Liver Content Will Improve Post-operative Liver Function in Patients Undergoing Major Liver Resections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older~* planned to undergo a major liver resection at McGill University Health Center (MUHC)~Exclusion Criteria:~* patients known with chronic viral liver disease~* uncontrolled or type one diabetes mellitus (DM)~* patients on oral beta-blocker agents~* patients with unresectable disease determined intra-operatively~* patients unable to give consent for the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): Intravenous normal saline (NS 0.9) started just before induction, and titrated to hemodynamic parameters and urine output
- GICP (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).